Solubility survey of fragments of the neurofibromatosis type 1 protein neurofibromin

Protein Expression and Purification

Volumn 65, Issue 1, 2009, Pages 30-37

  Bonneau, Fabien ^a   Lenherr, Esther D ^a   Pena, Vladimir ^a   Hart, Darren J ^b   Scheffzek, Klaus ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

Cancer; Disease protein; G protein regulator; Ras; Signal transduction; Tumor suppressor

Indexed keywords

NEUROFIBROMIN; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; NEUROFIBROMATOSIS; PHYSIOLOGY; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SOLUBILITY;

HUMANS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY;

EID: 60349085225     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.12.001     Document Type: Article

References (39)

1. DeClue J.E., Cohen B.D., and Lowy D.R. Identification and characterization of the neurofibromatosis type 1 protein product. Proc. Natl. Acad. Sci. USA 88 (1991) 9914-9918
2. Gutmann D.H., Wood D.L., and Collins F.S. Identification of the neurofibromatosis type 1 gene product. Proc. Natl. Acad. Sci. USA 88 (1991) 9658-9662
3. Upadhyaya M., and Cooper D.N. Neurofibromatosis type 1-from genotype to phenotype (1998), Bios Scientific Publishers, Oxford, Washington
4. Friedman J.M., Gutmann D.H., MacCollin M., and Riccardi V.M. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis (1999), Johns Hopkins University Press, Baltimore, Maryland
5. Cichowski K., and Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104 (2001) 593-604
6. Zhu Y., and Parada L.F. Neurofibromin, a tumor suppressor in the nervous system. Exp. Cell Res. 264 (2001) 19-28
7. Barbacid M. Ras genes. Annu. Rev. Biochem. 56 (1987) 779-827
8. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
9. Karnoub A.E., and Weinberg R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9 (2008) 517-531
10. Trahey M., and McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238 (1987) 542-545
11. Adari H., Lowy D.R., Willumsen B.M., Der C.J., and McCormick F. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240 (1988) 518-521
12. Bollag G., and McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351 (1991) 576-579
13. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., and Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63 (1990) 851-859
14. Martin G.A., Viskochil D., Bollag G., McCabe P.C., Crosier W.J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R.M., et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63 (1990) 843-849
15. Xu G.F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R., et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62 (1990) 599-608
16. Ahmadian M.R., Wiesmuller L., Lautwein A., Bischoff F.R., and Wittinghofer A. Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin. J. Biol. Chem. 271 (1996) 16409-16415
17. Scheffzek K., Ahmadian M.R., Kabsch W., Wiesmuller L., Lautwein A., Schmitz F., and Wittinghofer A. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277 (1997) 333-338
18. Ahmadian M.R., Stege P., Scheffzek K., and Wittinghofer A. Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat. Struct. Biol. 4 (1997) 686-689
19. Scheffzek K., Ahmadian M.R., Wiesmuller L., Kabsch W., Stege P., Schmitz F., and Wittinghofer A. Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J. 17 (1998) 4313-4327
20. S. Welti, I. D'Angelo, K. Scheffzek, in: M. Schmidt (Ed.), Neurofibromatoses, vol 16, Wuerzburg, Karger, 2008.
21. Aravind L., Neuwald A.F., and Ponting C.P. Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling [letter]. Curr. Biol. 9 (1999) R195-197
22. Bonneau F., D'Angelo I., Welti S., Stier G., Ylanne J., and Scheffzek K. Expression, purification and preliminary crystallographic characterization of a novel segment from the neurofibromatosis type 1 protein. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2364-2367
23. D'Angelo I., Welti S., Bonneau F., and Scheffzek K. A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 7 (2006) 174-179
24. Welti S., Fraterman S., D'Angelo I., Wilm M., and Scheffzek K. The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J. Mol. Biol. 366 (2007) 551-562
25. Izawa I., Tamaki N., and Saya H. Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett. 382 (1996) 53-59
26. Fahsold R., Hoffmeyer S., Mischung C., Gille C., Ehlers C., Kucukceylan N., Abdel-Nour M., Gewies A., Peters H., Kaufmann D., et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet. 66 (2000) 790-818
27. Bollag G., McCormick F., and Clark R. Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J. 12 (1993) 1923-1927
28. Tarendeau F., Boudet J., Guilligay D., Mas P.J., Bougault C.M., Boulo S., Baudin F., Ruigrok R.W., Daigle N., Ellenberg J., et al. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat. Struct. Mol. Biol. 14 (2007) 229-233
29. Tarendeau F., Crepin T., Guilligay D., Ruigrok R.W., Cusack S., and Hart D.J. Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit. PLoS Pathog. 4 (2008) e1000136
30. Guilligay D., Tarendeau F., Resa-Infante P., Coloma R., Crepin T., Sehr P., Lewis J., Ruigrok R.W., Ortin J., Hart D.J., et al. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 15 (2008) 500-506
31. Sambrook J., and Russell D.W. Molecular Cloning (2001), Cold Spring Harbor Laboratory Press
32. Apweiler R., Bairoch A., and Wu C.H. Protein sequence databases. Curr. Opin. Chem. Biol. 8 (2004) 76-80
33. Mangoura D., Sun Y., Li C., Singh D., Gutmann D.H., Flores A., Ahmed M., and Vallianatos G. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 25 (2006) 735-745
34. Scheffzek K., Ahmadian M.R., Wiesmuller L., Kabsch W., Stege P., Schmitz F., and Wittinghofer A. Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J. 17 (1998) 4313-4327
35. Saito K., Tautz L., and Mustelin T. The lipid-binding SEC14 domain. Biochim. Biophys. Acta 1771 (2007) 719-726
36. Lemmon M.A. Pleckstrin homology domains: not just for phosphoinositides. Biochem. Soc. Trans. 32 (2004) 707-711
37. Andrade M.A., and Bork P. HEAT repeats in the Huntington's disease protein. Nat. Genet. 11 (1995) 115-116
38. Hsueh Y.P., Roberts A.M., Volta M., Sheng M., and Roberts R.G. Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J. Neurosci. 21 (2001) 3764-3770
39. Cichowski K., Santiago S., Jardim M., Johnson B.W., and Jacks T. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev. 17 (2003) 449-454